Short talk therapy may stop PTSD before it starts

NCT ID NCT06210711

Recruiting now Prevention Sponsor: Baylor Research Institute Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a short form of exposure therapy, given soon after a traumatic injury, can prevent posttraumatic stress disorder (PTSD). Researchers will enroll 300 injured adults admitted to Level I trauma centers. Half will receive the brief therapy plus standard care, and half will receive standard care alone. The goal is to see if early intervention can reduce PTSD symptoms and improve recovery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Brief Prolonged Exposure Therapy (a short course of trauma-focused talk therapy)
What this could lead to: If it works, this could provide a simple, early intervention to prevent PTSD from developing after a traumatic injury.
What could go wrong: This is a relatively small, early-stage trial. The therapy may not be more effective than standard care, and results may not apply to all trauma survivors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTTRAUMATIC STRESS DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

injury post-traumatic stress disorder prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POSTTRAUMATIC STRESS DISORDER PTSD TRAUMATIC INJURY

Contacts and locations

Locations

Baylor Scott & White Medical Center - Temple
RECRUITING

Temple, Texas, 76508, United States
Baylor University Medical Center
RECRUITING

Dallas, Texas, 75246, United States
Froedtert & Medical College of Wisconsin
RECRUITING

Milwaukee, Wisconsin, 53226, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.